Endoscopic management of upper-tract urothelial carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523–1525.
   PubMed Web of Science ®Google Scholar
• Raman JD, Messer J, Sielatycki JA, et al. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. 2011;107(7):1059–1064.
   PubMed Web of Science ®Google Scholar
• Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010;57(6):1072–1079.
   PubMed Web of Science ®Google Scholar
• Yoo S, You D, Jeong IG, et al. Impact of tumor location on local recurrence after nephroureterectomy for upper tract urothelial carcinoma: implications for adjuvant radiotherapy. Clin Genitourin Cancer. 2017 Apr;15(2):e199–e204. doi: 10.1016/j.clgc.2016.07.010. Epub 2016 Jul 21.
   PubMedGoogle Scholar
• Petrelli F, Yasser Hussein MI, Vavassori I, et al. Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis. Urology. 2017;100:9–15.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Babjuk M, Compérat E, et al. European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868–879.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Yates DR, Comperat E, et al. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 2008;54(6):1226–1236.
   PubMed Web of Science ®Google Scholar
• Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–1233.
   PubMed Web of Science ®Google Scholar
• Alvarez-Maestro M, Rivas JG, Gregorio SA, et al. Current role of lymphadenectomy in the upper tract urothelial carcinoma. Cent European J Urol. 2016;69(4):384–390.
   PubMed Web of Science ®Google Scholar
• Raman JD, Jafri SM. Complications following radical nephroureterectomy. Curr Urol Rep. 2016;17(5):36.
   PubMed Web of Science ®Google Scholar
• Lin YK, Deliere A, Lehman K, et al. Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma. Can J Urol. 2014;21(4):7369–7373.
   PubMed Web of Science ®Google Scholar
• Raman JD, Lin YK, Kaag M, et al. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol. 2014;32(1):47 e49–e14.
   Web of Science ®Google Scholar
• Raman JD, Lin YK, Shariat SF, et al. Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy. BJU Int. 2017;119(2):268–275.
   PubMed Web of Science ®Google Scholar
• Smith P, Mandel J, Raman JD. Conservative nephron-sparing treatment of upper-tract tumors. Curr Urol Rep. 2013;14(2):102–108.
   PubMed Web of Science ®Google Scholar
• Jinzaki M, Kikuchi E, Akita H, et al. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. Int J Urol. 2016;23(4):284–298.
   PubMed Web of Science ®Google Scholar
• Raman SP, Fishman EK. Upper and lower tract urothelial imaging using computed tomography urography. Radiol Clin North Am. 2017;55(2):225–241.
   PubMed Web of Science ®Google Scholar
• Tian Y, Gong Y, Pang Y, et al. Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis. PeerJ. 2016;4:e2144.
   PubMed Web of Science ®Google Scholar
• Bus MT, de Bruin DM, Faber DJ, et al. Optical coherence tomography as a tool for in vivo staging and grading of upper urinary tract urothelial carcinoma: a study of diagnostic accuracy. J Urol. 2016;196(6):1749–1755.
   PubMed Web of Science ®Google Scholar
• Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound Med. 2010;29(9):1277–1284.
   PubMed Web of Science ®Google Scholar
• Clements T, Messer JC, Terrell JD, et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012;26(4):398–402.
   PubMed Web of Science ®Google Scholar
• Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157(1):33–37.
   PubMed Web of Science ®Google Scholar
• Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011;108(5):701–705.
   PubMed Web of Science ®Google Scholar
• Potretzke AM, Knight BA, Vetter JM, et al. Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature. Urology. 2016;96:35–43.
   PubMed Web of Science ®Google Scholar
• Brien JC, Shariat SF, Herman MP, et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 2010;184(1):69–73.
   PubMed Web of Science ®Google Scholar
• Favaretto RL, Shariat SF, Savage C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2012;109(1):77–82.
   PubMed Web of Science ®Google Scholar
• Raman JD. Kidney sparing surgery for upper-tract urothelial carcinoma. Minerva Urol Nefrol. 2016;68(4):359–371.
   PubMed Web of Science ®Google Scholar
• Seisen T, Colin P, Rouprêt M. Risk-adapted strategy for the kidney-sparing management of upper tract tumours. Nat Rev Urol. 2015;12(3):155–166.
   PubMed Web of Science ®Google Scholar
• Soderdahl DW, Fabrizio MD, Rahman NU, et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol. 2005;23(2):114–122.
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
   PubMed Web of Science ®Google Scholar
• Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–740.
   PubMed Web of Science ®Google Scholar
• Pak RW, Moskowitz EJ, Bagley DH. What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol. 2009;23(3):341–346.
   PubMed Web of Science ®Google Scholar
• Box GN, Lehman DS, Landman J, et al. Minimally invasive management of upper tract malignancies: renal cell and transitional cell carcinoma. Urol Clin North Am. 2008;35(3):365–383, vii.
   PubMed Web of Science ®Google Scholar
• Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 2007;4(8):432–443.
   PubMedGoogle Scholar
• Cho SY. Current status of flexible ureteroscopy in urology. Korean J Urol. 2015;56(10):680–688.
   PubMedGoogle Scholar
• Suh LK, Rothberg MB, Landman J, et al. Intrarenal pressures generated during deployment of various antiretropulsion devices in an ex vivo porcine model. J Endourol. 2010;24(7):1165–1168.
   PubMed Web of Science ®Google Scholar
• Frees S, Bidnur S, Metcalfe M, et al. Effect of contrast media on urinary cytopathology specimens. Can Urol Assoc J. 2016;10(7–8):228–233.
   PubMed Web of Science ®Google Scholar
• Fang D, Xiong G, Li X, et al. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol. 2015;33(2):66 e61–e11.
   Web of Science ®Google Scholar
• Auge BK, Pietrow PK, Lallas CD, et al. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004;18(1):33–36.
   PubMed Web of Science ®Google Scholar
• Gorin MA, Santos Cortes JA, Kyle CC, et al. Initial clinical experience with use of ureteral access sheaths in the diagnosis and treatment of upper tract urothelial carcinoma. Urology. 2011;78(3):523–527.
   PubMed Web of Science ®Google Scholar
• Kleinmann N, Healy KA, Hubosky SG, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps. J Endourol. 2013;27(12):1450–1454.
   PubMed Web of Science ®Google Scholar
• Sung HH, Jeon HG, Han DH, et al. Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract urothelial carcinoma. PLoS One. 2015;10(11):e0139976.
   PubMed Web of Science ®Google Scholar
• Yoo S, You D, Song C, et al. Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the location matter? J Endourol. 2017;31(3):259–265.
   PubMed Web of Science ®Google Scholar
• Fiuk JV, Schwartz BF. Upper tract urothelial carcinoma: paradigm shift towards nephron sparing management. World J Nephrol. 2016;5(2):158–165.
   PubMedGoogle Scholar
• Motamedinia P, Hoenig D, Okeke Z, et al. A case for nephron sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2016;30(Suppl 1):S18–S22.
   PubMed Web of Science ®Google Scholar
• Suriano F, Brancato T. Nephron-sparing management of upper tract urothelial carcinoma. Rev Urol. 2014;16(1):21–28.
   PubMedGoogle Scholar
• Bader MJ, Sroka R, Gratzke C, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol. 2009;56(1):65–71.
   PubMed Web of Science ®Google Scholar
• Adamis S, Varkarakis J. Minimally invasive approach in the management of upper- urinary-tract tumours. Scand J Urol Nephrol. 2011;45(6):381–387.
   PubMed Web of Science ®Google Scholar
• Fajkovic H, Klatte T, Nagele U, et al. Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience. World J Urol. 2013;31(1):37–44.
   PubMed Web of Science ®Google Scholar
• Grasso M, Fishman AI, Cohen J, et al. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int. 2012;110(11):1618–1626.
   PubMed Web of Science ®Google Scholar
• Cutress ML, Stewart GD, Wells-Cole S, et al. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int. 2012;110(11):1608–1617.
   PubMed Web of Science ®Google Scholar
• Raymundo EM, Lipkin ME, Bañez LB, et al. Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2011;25(3):377–384.
   PubMed Web of Science ®Google Scholar
• Gadzinski AJ, Roberts WW, Faerber GJ, et al. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol. 2010;183(6):2148–2153.
   PubMed Web of Science ®Google Scholar
• Cornu JN, Roupret M, Carpentier X, et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol. 2010;28(2):151–156.
   PubMed Web of Science ®Google Scholar
• Lucas SM, Svatek RS, Olgin G, et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int. 2008;102(2):172–176.
   PubMed Web of Science ®Google Scholar
• Thompson RH, Krambeck AE, Lohse CM, et al. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology. 2008;71(4):713–717.
   PubMed Web of Science ®Google Scholar
• Krambeck AE, Thompson RH, Lohse CM, et al. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J Urol. 1721–1726;177(5):2007.
   Google Scholar
• Reisiger K, Hruby G, Clayman RV, et al. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome. Urology. 2007;70(2):263–266.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67(6):1181–1187.
   PubMed Web of Science ®Google Scholar
• Johnson GB, Grasso M. Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr Opin Urol. 2005;15(2):89–93.
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Lida S, Tomiyasu K, et al. Transurethral endoscopic treatment of upper urinary tract tumors using a holmium: yAGlaser. Lasers Surg Med. 2003;32(5):336–340.
   PubMed Web of Science ®Google Scholar
• Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003;98(1):55–60.
   PubMed Web of Science ®Google Scholar
• Boorjian S, Ng C, Munver R, et al. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology. 2005;66(2):283–287.
   PubMed Web of Science ®Google Scholar
• Gurbuz C, Youssef RF, Shariat SF, et al. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol. 2011;25(5):775–779.
   PubMed Web of Science ®Google Scholar
• Jabbour ME, Desgrandchamps F, Cazin S, et al., Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol. 2000;1634:1105–1107. quiz 1295
   PubMed Web of Science ®Google Scholar
• Jabbour ME, Smith AD. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am. 2000;27(4):739–750.
   PubMed Web of Science ®Google Scholar
• Liatsikos EN, Dinlenc CZ, Kapoor R, et al., Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. J Endourol. 2001;154:377–383. discussion 397
   PubMed Web of Science ®Google Scholar
• Cutress ML, Stewart GD, Zakikhani P, et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110(5):614–628.
   PubMed Web of Science ®Google Scholar
• Argyropoulos AN, Tolley DA. Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches. BJU Int. 2007;99(5):982–987.
   PubMed Web of Science ®Google Scholar
• Clark PE, Streem SB. Endourologic management of upper tract transitional cell carcinoma. Sci World J. 2004;4(Suppl 1):62–75.
   Google Scholar
• Okeke Z, Andonian S, Srinivasan A, et al. Cryotherapy of the nephrostomy tract: a novel technique to decrease the risk of hemorrhage after tubeless percutaneous renal surgery. J Endourol. 2009;23(3):417–420.
   PubMed Web of Science ®Google Scholar
• Storm DW, Fulmer BR. Case report: percutaneous management of transitional-cell carcinoma of the upper urinary tract using the bipolar resectoscope. J Endourol. 2007;21(9):1011–1013.
   PubMed Web of Science ®Google Scholar
• Motamedinia P, Keheila M, Leavitt DA, et al. The expanded use of percutaneous resection for upper tract urothelial carcinoma: a 30-year comprehensive experience. J Endourol. 2016;30(3):262–267.
   PubMed Web of Science ®Google Scholar
• Rastinehad AR, Ost MC, Vanderbrink BA, et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy? Urology. 2009;73(1):27–31.
   PubMed Web of Science ®Google Scholar
• Palou J, Piovesan LF, Huguet J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol. 2004;172(1):66–69.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Traxer O, Tligui M, et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol. 2007;513:709–713. discussion 714
   PubMed Web of Science ®Google Scholar
• Goel MC, Mahendra V, Roberts JG, Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol. 2003;1693:925–929. discussion 929-930
   PubMed Web of Science ®Google Scholar
• Suh RS, Faerber GJ, Wolf JS Jr. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol. 2003;170(6 Pt 1):2209–2216.
   PubMed Web of Science ®Google Scholar
• Clark PE, Streem SB, Geisinger MA, 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol. 1999;1613:772–775. discussion 775-776
   PubMed Web of Science ®Google Scholar
• Jarrett TW, Sweetser PM, Weiss GH, et al. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol. 1995;154(5):1629–1635.
   PubMed Web of Science ®Google Scholar
• Lee BR, Jabbour ME, Marshall FF, et al. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. J Endourol. 1999;13(4):289–294.
   PubMed Web of Science ®Google Scholar
• Chou R, Selph S, Buckley DI, et al. Intravesical therapy for the treatment of non-muscle-invasive bladder cancer: a systematic review and meta-analysis. J Urol. 2017 May;197(5):1189–1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
   PubMed Web of Science ®Google Scholar
• Pollard ME, Levinson AW, Shapiro EY, et al. Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model. Urology. 2013;82(6):1451 e1451–1456.
   Web of Science ®Google Scholar
• Wang AJ, Goldsmith ZG, Neisius A, et al. Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer. J Endourol. 2013;27(3):288–293.
   PubMed Web of Science ®Google Scholar
• Donin NM, Duarte S, Lenis AT, et al. Sustained-release formulation of mitomycin c to the upper urinary tract using a thermosensitive polymer: a preclinical study. Urology. 2017;99:270–277.
   PubMed Web of Science ®Google Scholar
• Donin NM, Strauss-Ayali D, Agmon-Gerstein Y, et al. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: safety and feasibility. Urol Oncol. 2017 May;35(5):272–278. doi: 10.1016/j.urolonc.2016.11.019. Epub 2017 Jan 3.
   PubMed Web of Science ®Google Scholar
• Redrow GP, Guo CC, Brausi MA, et al. Upper urinary tract carcinoma in situ: current knowledge, future direction. J Urol. 2017;197(2):287–295.
   PubMed Web of Science ®Google Scholar
• Thalmann GN, Markwalder R, Walter B, et al. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168(4 Pt 1):1381–1385.
   PubMed Web of Science ®Google Scholar
• Giannarini G, Kessler TM, Birkhäuser FD, et al. Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol. 2011;60(5):955–960.
   PubMed Web of Science ®Google Scholar
• Rastinehad AR, Smith AD. Bacillus Calmette-Guerin for upper tract urothelial cancer: is there a role? J Endourol. 2009;23(4):563–568.
   PubMed Web of Science ®Google Scholar
• Keeley FX Jr., Bagley DH. Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. J Urol. 1997;158(6):2074–2077.
   PubMed Web of Science ®Google Scholar
• Aboumarzouk OM, Somani B, Ahmad S, et al. Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma. Urol Ann. 2013;5(3):184–189.
   PubMedGoogle Scholar
• Kauffman EC, Raman JD. Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther. 2008;8(1):75–85.
   PubMed Web of Science ®Google Scholar
• Raman JD, Ng CK, Boorjian SA, et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 2005;96(7):1031–1035.
   PubMed Web of Science ®Google Scholar
• O’Brien T, Ray E, Singh R, et al. British Association of Urological Surgeons Section of O. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011;60(4):703–710.
   PubMed Web of Science ®Google Scholar
• Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31(11):1422–1427.
   PubMed Web of Science ®Google Scholar
• Lu DD, Boorjian SA, Raman JD. Intravesical chemotherapy use after radical nephroureterectomy: a national survey of urologic oncologists. Urol Oncol. 2017 Mar;35(3):113.e1–113.e7. doi: 10.1016/j.urolonc.2016.10.016. Epub 2016 Nov 22.
   Google Scholar
• Power NE, Izawa J. Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE). Bladder Cancer. 2016;2(1):27–36.
   PubMedGoogle Scholar
• Villa L, Cloutier J, Letendre J, et al. Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol. 2016;34(9):1201–1206.
   PubMed Web of Science ®Google Scholar
• Borofsky MS, Shah O. Advances in ureteroscopy. Urol Clin North Am. 2013;40(1):67–78.
   PubMed Web of Science ®Google Scholar
• Wetherell DR, Ling D, Ow D, et al. Advances in ureteroscopy. Transl Androl Urol. 2014;3(3):321–327.
   PubMedGoogle Scholar
• Chen SP, Liao JC. Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis? Curr Urol Rep. 2014;15(9):437.
   PubMed Web of Science ®Google Scholar